1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Chronic Phase Chronic Myeloid Leukemia: new trials by email Literature Review of Chronic Phase Chronic Myeloid Leukemia trials Research Report on Chronic Phase Chronic Myeloid Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Comparing Ponatinib and Nilotinib in Participants With Chronic Myeloid Leukemia Ponatinib 30 mg QD, Ponatinib 15 mg QD, Nilotinib 400 mg BID - Chronic Phase Chronic Myeloid Leukemia | Phase 3 | Terminated | Ariad Pharmaceuticals | 44 | 2015-12-31 | 2021-11-26 |
Bone Marrow Diseases (1) · Hematologic Diseases (1) · Leukemia (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid (1) · Leukemia, Myeloid, Chronic-Phase (1) · Myeloproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Chronic Disease (1) · Disease Attributes (1) · Hemic and Lymphatic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
BID protein, human (1) · nilotinib (1) · ponatinib (1)
Belgium (1)
2015 (1)